These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104 [TBL] [Abstract][Full Text] [Related]
3. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation. Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303 [TBL] [Abstract][Full Text] [Related]
4. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection. Price AM; Messinger JE; Luftig MA J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124 [TBL] [Abstract][Full Text] [Related]
5. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions. Rowe M; Raithatha S; Shannon-Lowe C J Virol; 2014 Oct; 88(20):12065-76. PubMed ID: 25122803 [TBL] [Abstract][Full Text] [Related]
6. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation. Harada S; Yalamanchili R; Kieff E J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732 [TBL] [Abstract][Full Text] [Related]
7. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes. Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051 [TBL] [Abstract][Full Text] [Related]
8. The Epstein-Barr virus nuclear antigen-1 upregulates the cellular antioxidant defense to enable B-cell growth transformation and immortalization. Wang J; Nagy N; Masucci MG Oncogene; 2020 Jan; 39(3):603-616. PubMed ID: 31511648 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. Kilger E; Kieser A; Baumann M; Hammerschmidt W EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091 [TBL] [Abstract][Full Text] [Related]
10. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival. Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277 [TBL] [Abstract][Full Text] [Related]
11. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway. Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549 [TBL] [Abstract][Full Text] [Related]
12. First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. Pich D; Mrozek-Gorska P; Bouvet M; Sugimoto A; Akidil E; Grundhoff A; Hamperl S; Ling PD; Hammerschmidt W mBio; 2019 Sep; 10(5):. PubMed ID: 31530670 [TBL] [Abstract][Full Text] [Related]
13. C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7. Cancian L; Bosshard R; Lucchesi W; Karstegl CE; Farrell PJ PLoS Pathog; 2011 Jul; 7(7):e1002164. PubMed ID: 21857817 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation. Price AM; Tourigny JP; Forte E; Salinas RE; Dave SS; Luftig MA J Virol; 2012 Oct; 86(20):11096-106. PubMed ID: 22855490 [TBL] [Abstract][Full Text] [Related]
15. Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1. Wang Q; Lingel A; Geiser V; Kwapnoski Z; Zhang L J Virol; 2017 Oct; 91(20):. PubMed ID: 28794023 [TBL] [Abstract][Full Text] [Related]
16. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells. Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904 [TBL] [Abstract][Full Text] [Related]
17. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Chen A; Zhao B; Kieff E; Aster JC; Wang F J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691 [TBL] [Abstract][Full Text] [Related]
18. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation. Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1. Martin KA; Lupey LN; Tempera I J Virol; 2016 Oct; 90(19):8520-30. PubMed ID: 27440880 [TBL] [Abstract][Full Text] [Related]
20. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation. Smith N; Tierney R; Wei W; Vockerodt M; Murray PG; Woodman CB; Rowe M PLoS One; 2013; 8(5):e64868. PubMed ID: 23724103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]